Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
6,672.00
6,228.00
5,652.00
5,305.00
5,393.00
4,605.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
6,672.00
6,228.00
5,652.00
5,305.00
5,393.00
4,605.00
Expenditure (Ex Depriciation)
Stock Adjustments
-289.00
-142.00
78.00
-43.00
-193.00
-210.00
Raw Materials Consumed
2,083.00
1,857.00
1,630.00
1,489.00
1,451.00
1,249.00
Power & Fuel Cost
179.00
173.00
151.00
120.00
118.00
102.00
Employee Cost
1,562.00
1,446.00
1,169.00
1,133.00
1,051.00
906.00
Operating Expenses
431.00
366.00
380.00
328.00
346.00
325.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
1,064.00
996.00
952.00
890.00
696.00
531.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
46.00
50.00
60.00
47.00
-44.00
95.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
5,663.00
5,295.00
4,944.00
4,431.00
3,835.00
3,382.00
Operating Profit (PBDIT) excl Other Income
1,008.00
933.00
708.00
874.00
1,557.00
1,223.00
Other Income
42.00
28.00
2.00
50.00
10.00
4.00
Operating Profit (PBDIT)
1,050.00
961.00
711.00
924.00
1,567.00
1,227.00
Interest
78.00
56.00
50.00
17.00
16.00
27.00
Profit before Depriciation and Tax
972.00
905.00
660.00
906.00
1,551.00
1,200.00
Depreciation
278.00
272.00
275.00
286.00
183.00
157.00
Profit Before Taxation & Exceptional Items
693.00
632.00
385.00
620.00
1,368.00
1,043.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
707.00
631.00
354.00
625.00
1,368.00
999.00
Provision for Tax
125.00
16.00
12.00
104.00
253.00
199.00
Profit After Tax
581.00
616.00
372.00
515.00
1,114.00
800.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
4,027.00
3,568.00
2,554.00
2,384.00
1,538.00
1,286.00
Profit Available for appropriations
4,610.00
4,184.00
2,896.00
2,905.00
2,716.00
2,115.00
Appropriations
4,610.00
4,184.00
2,896.00
2,905.00
2,716.00
2,115.00
Equity Dividend (%)
550.00%
550.00%
400.00%
500.00%
700.00%
500.00%
Earnings Per Share
29.68
31.33
17.40
26.50
60.81
43.97
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 7.12% vs 10.19% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 8.02% vs 31.76% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 40.19% vs 12.00% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -5.78% vs 65.40% in Mar 2024
Compare Profit and Loss Results of Alembic Pharma
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
6,672.00
1,694.00
4,978.00
293.86%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
6,672.00
1,694.00
4,978.00
293.86%
Expenditure (Ex Depriciation)
Stock Adjustments
-289.00
4.00
-293.00
-7,325.00%
Raw Materials Consumed
2,083.00
460.00
1,623.00
352.83%
Power & Fuel Cost
179.00
48.00
131.00
272.92%
Employee Cost
1,562.00
549.00
1,013.00
184.52%
Operating Expenses
431.00
94.00
337.00
358.51%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1,064.00
11.00
1,053.00
9,572.73%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
46.00
35.00
11.00
31.43%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
5,663.00
1,286.00
4,377.00
340.36%
Operating Profit (PBDIT) excl Other Income
1,008.00
407.00
601.00
147.67%
Other Income
42.00
36.00
6.00
16.67%
Operating Profit (PBDIT)
1,050.00
444.00
606.00
136.49%
Interest
78.00
78.00
0.00
0.00%
Profit before Depriciation and Tax
972.00
366.00
606.00
165.57%
Depreciation
278.00
138.00
140.00
101.45%
Profit Before Taxation & Exceptional Items
693.00
227.00
466.00
205.29%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
707.00
227.00
480.00
211.45%
Provision for Tax
125.00
57.00
68.00
119.30%
Profit After Tax
581.00
170.00
411.00
241.76%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
4,027.00
553.00
3,474.00
628.21%
Profit Available for appropriations
4,610.00
723.00
3,887.00
537.62%
Appropriations
4,610.00
723.00
3,887.00
537.62%
Equity Dividend (%)
550%
0%
550.00
Earnings Per Share
29.68
8.83
20.85
236.13%
Profit And Loss - Net Sales
Net Sales 6,672.08 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 7.12% vs 10.19% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,008.24 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 8.02% vs 31.76% in Mar 2024
Profit And Loss - Interest
Interest 78.77 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 40.19% vs 12.00% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 581.14 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -5.78% vs 65.40% in Mar 2024






